Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1997-02-05
1998-12-15
LeGuyader, John L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
536 231, 536 2431, 435 6, 435 911, 4351723, 435325, 435354, 435366, 435375, 514 44, C07H 2100, C07H 2104, C12Q 168, C12N 1585
Patent
active
058499032
ABSTRACT:
Oligonucleotides are provided which are effective in inhibiting the growth, metastasis and/or angiogenesis of tumors, including particularly melanoma and/or lung cancer. Methods are also provided for use of these oligonucleotides in the treatment of diseases.
REFERENCES:
Agrawal Antisense oligonucleotides: Towards Clinical Trials TibTech vol. 14:376-387, 1996.
Sten & Kreig "Problems in intepretation of Data Derived from in vitro and in vivo use of Antisense Oligondeoxynucleotides." antisense Research and Development. vol. 4:67:69, 1994.
Stull et al. "Antigene, Ribozyme and Aptamer Nucleic Acid Drugs: Progress and Prospects." Pharmaceutical Research vol. 12(4):465-483, 1995.
Cieslak Dariusz
Olbina Gordana
Pietrzkowski Zbigniew
ICN Pharmaceuticals, Inc.
LeGuyader John L.
M'Garry Sean
LandOfFree
Antisense oligonucleotides for IL-8 and IL-8 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides for IL-8 and IL-8 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides for IL-8 and IL-8 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1459372